ALI FARAZ (Chief Executive Officer) sold 5.1% of their position (22.23K shares) of TENAYA THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/18/2026ACC: 0001193125-26-354518
DirectorOfficer· Chief Executive Officer
Since Jul 2021
-22.23K
Net shares
Net seller
$15.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
22.23K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−5.84K
Price / share
$0.71
Trade value
$4.14K
% of position
1.3%
8/17/2026
440.01K→434.18K
Common Stock
Direct
Shares
−3.97K
Price / share
$0.71
Trade value
$2.82K
% of position
0.9%
8/17/2026
434.18K→430.21K
Common Stock
Direct
Shares
−5.02K
Price / share
$0.71
Trade value
$3.56K
% of position
1.2%
8/17/2026
430.21K→425.19K
Common Stock
Direct
Shares
−7.41K
Price / share
$0.71
Trade value
$5.26K
% of position
1.7%
8/17/2026
425.19K→417.78K
Total
Net shares
−22.23K
Net value
-$15.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | S · Sale | −5.84K | $0.71 | $4.14K | 1.3% | 440.01K | 434.18K |
| Common Stock Direct | 8/17/2026 | S · Sale | −3.97K | $0.71 | $2.82K | 0.9% | 434.18K | 430.21K |
| Common Stock Direct | 8/17/2026 | S · Sale | −5.02K | $0.71 | $3.56K | 1.2% | 430.21K | 425.19K |
| Common Stock Direct | 8/17/2026 | S · Sale | −7.41K | $0.71 | $5.26K | 1.7% | 425.19K | 417.78K |
| Total | −22.23K | -$15.78K | ||||||
Derivative Transactions0
No derivative transactions reported